Dahlia Sano, MD
Hematology · Ann Arbor, MINPI 1659631729
Payments from drug & device makers
Across 264 payments — averaging $11,355 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$1.1M
- Pharmacyclics LLC, An Abbvie Company$543K
- Seagen Inc.$354K
- Pfizer$295K
- Beone Medicines Ltd.$262K
- Epizyme, Inc.$139K
- plus $277K from 12 others
Across 4 payments — averaging $978.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$2K
- F. Hoffmann-la Roche AG$1K
- Pfizer$940
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 68 | $1,127,601 |
| Pharmacyclics LLC, An Abbvie Company | 11 | $543,095 |
| Seagen Inc. | 60 | $353,510 |
| Pfizer | 15 | $295,414 |
| Beone Medicines Ltd. | 4 | $262,000 |
| Epizyme, Inc. | 44 | $138,965 |
| Acerta Pharma LLC | 10 | $90,854 |
| Eli Lilly | 4 | $54,990 |
| Merck | 7 | $41,677 |
| Beigene, Ltd. | 18 | $37,798 |
| Karyopharm Therapeutics Inc. | 3 | $26,280 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $19,309 |
| AstraZeneca | 2 | $5,012 |
| Novartis | 5 | $888 |
| Icotec Medical Inc. | 3 | $152 |
| Johnson & Johnson | 1 | $99 |
| Adaptive Biotechnologies Corporation | 1 | $90 |
| Beigene USA, Inc. | 1 | $50 |
How this compares
$2,997,784 in reported general payments places this provider in the 95th percentile of 50 hematology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology in Ann Arbor
- Matthew PiankoAnn Arbor$5.7M
- Yasmin KarimiAnn Arbor$3M
- Sarah AnandAnn Arbor$2.5M
- Erica CampagnaroAnn Arbor$2.4M
- John MagenauAnn Arbor$2.2M
- Kristen PettitAnn Arbor$1.5M
- Charles FoucarAnn Arbor$830K
- Patrick BurkeAnn Arbor$635K
- Dale BixbyAnn Arbor$581K
- Albert QuieryAnn Arbor$317K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.